Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients
- PMID: 25831462
- DOI: 10.1001/jamasurg.2015.0219
Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients
Abstract
Importance: Whereas conventional actuarial overall survival (OS) estimates rely exclusively on static factors determined around the time of surgery, conditional survival (CS) estimates take into account the years that a patient has already survived.
Objective: To define the CS of patients following liver resection for intrahepatic cholangiocarcinoma (ICC).
Design, setting, and participants: Between January 1, 1990, and December 31, 2013, a total of 535 patients who underwent resection of ICC were identified from an international multi-institutional database. In this retrospective international study conducted from January to June 2014, clinicopathological characteristics, operative details, and long-term survival data were analyzed. Conditional survival estimates were calculated as the probability of survival for an additional 3 years.
Intervention: Resection of ICC.
Main outcomes and measures: Overall survival and CS.
Results: While actuarial OS decreased over time from 39% at 3 years to 16% at 8 years (P = .002), the 3-year CS (CS₃) increased over time among those patients who survived. The CS₃ at 5 years-the probability of surviving to postoperative year 8 after having already survived to postoperative year 5-was 65% compared with 8-year OS of 16% (P = .002). Factors that were associated with worse OS included larger tumor size (hazard ratio [HR], 1.02; 95% CI, 1.00-1.05; P = .05), multifocal disease (HR, 1.49; 95% CI, 1.19-1.86; P = .01), lymph node metastasis (HR, 2.21; 95% CI, 1.67-2.93; P < .01), and vascular invasion (HR, 1.39; 95% CI, 1.10-1.75; P = .006). The calculated CS₃ exceeded the actuarial survival for all high-risk subgroups. For example, patients with lymph node metastasis had an actuarial OS of 11% at 6 years vs a CS₃ of 49% at 3 years (Δ38%). Similarly, patients with vascular invasion had an actuarial OS of 15% at 6 years compared with a CS₃ of 50% at 3 years (Δ35%).
Conclusions and relevance: Conditional survival estimates may provide critical quantitative information about the changing probability of survival over time among patients undergoing liver resection for ICC. Therefore, such estimates can be of significant value to patients and health care professionals.
Comment in
-
Determining Chances for Survival in Intrahepatic Cholangiocarcinoma.JAMA Surg. 2015 Jun;150(6):546. doi: 10.1001/jamasurg.2015.0236. JAMA Surg. 2015. PMID: 25831124 No abstract available.
Similar articles
-
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.JAMA Surg. 2014 May;149(5):432-8. doi: 10.1001/jamasurg.2013.5168. JAMA Surg. 2014. PMID: 24599477
-
Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.Hepatogastroenterology. 2007 Mar;54(74):346-9. Hepatogastroenterology. 2007. PMID: 17523271
-
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6. Hepatogastroenterology. 2002. PMID: 11995440
-
What constitutes long-term survival after surgery for hilar cholangiocarcinoma?Cancer. 1997 Jan 1;79(1):26-34. Cancer. 1997. PMID: 8988723 Review.
-
Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date.J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):162-8. doi: 10.1002/jhbp.30. Epub 2013 Sep 11. J Hepatobiliary Pancreat Sci. 2014. PMID: 24027075 Review.
Cited by
-
Conditional survival analysis of patients with resected non-small cell lung cancer.JTCVS Open. 2023 Sep 18;16:948-959. doi: 10.1016/j.xjon.2023.09.010. eCollection 2023 Dec. JTCVS Open. 2023. PMID: 38204712 Free PMC article.
-
Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma.BMC Cancer. 2022 Mar 11;22(1):258. doi: 10.1186/s12885-022-09352-3. BMC Cancer. 2022. PMID: 35277130 Free PMC article.
-
Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis.Exp Biol Med (Maywood). 2022 Sep;247(18):1657-1669. doi: 10.1177/15353702221113828. Epub 2022 Aug 10. Exp Biol Med (Maywood). 2022. PMID: 35946168 Free PMC article.
-
Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018.Cancer Control. 2023 Jan-Dec;30:10732748231211764. doi: 10.1177/10732748231211764. Cancer Control. 2023. PMID: 37926828 Free PMC article.
-
Roles of the Immune/Methylation/Autophagy Landscape on Single-Cell Genotypes and Stroke Risk in Breast Cancer Microenvironment.Oxid Med Cell Longev. 2021 Aug 19;2021:5633514. doi: 10.1155/2021/5633514. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34457116 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical